110 related articles for article (PubMed ID: 24801591)
1. Impaired health-related quality of life in Addison's disease--impact of replacement therapy, comorbidities and socio-economic factors.
Kluger N; Matikainen N; Sintonen H; Ranki A; Roine RP; Schalin-Jäntti C
Clin Endocrinol (Oxf); 2014 Oct; 81(4):511-8. PubMed ID: 24801591
[TBL] [Abstract][Full Text] [Related]
2. Continuous subcutaneous hydrocortisone infusion therapy in Addison's disease: a randomized, placebo-controlled clinical trial.
Gagliardi L; Nenke MA; Thynne TR; von der Borch J; Rankin WA; Henley DE; Sorbello J; Inder WJ; Torpy DJ
J Clin Endocrinol Metab; 2014 Nov; 99(11):4149-57. PubMed ID: 25127090
[TBL] [Abstract][Full Text] [Related]
3. Improvement of anthropometric and metabolic parameters, and quality of life following treatment with dual-release hydrocortisone in patients with Addison's disease.
Giordano R; Guaraldi F; Marinazzo E; Fumarola F; Rampino A; Berardelli R; Karamouzis I; Lucchiari M; Manetta T; Mengozzi G; Arvat E; Ghigo E
Endocrine; 2016 Feb; 51(2):360-8. PubMed ID: 26184416
[TBL] [Abstract][Full Text] [Related]
4. Continuous subcutaneous hydrocortisone infusion versus oral hydrocortisone replacement for treatment of addison's disease: a randomized clinical trial.
Oksnes M; Björnsdottir S; Isaksson M; Methlie P; Carlsen S; Nilsen RM; Broman JE; Triebner K; Kämpe O; Hulting AL; Bensing S; Husebye ES; Løvås K
J Clin Endocrinol Metab; 2014 May; 99(5):1665-74. PubMed ID: 24517155
[TBL] [Abstract][Full Text] [Related]
5. Normal long-term health-related quality of life can be achieved in patients with functional pituitary adenomas having surgery as primary treatment.
Ritvonen E; Karppinen A; Sintonen H; Vehkavaara S; Kivipelto L; Roine RP; Niemelä M; Schalin-Jäntti C
Clin Endocrinol (Oxf); 2015 Mar; 82(3):412-21. PubMed ID: 25039500
[TBL] [Abstract][Full Text] [Related]
6. Health-related quality of life in patients treated for nonfunctioning pituitary adenomas during the years 2000-2010.
Karppinen A; Ritvonen E; Roine R; Sintonen H; Vehkavaara S; Kivipelto L; Grossman AB; Niemelä M; Schalin-Jäntti C
Clin Endocrinol (Oxf); 2016 Apr; 84(4):532-9. PubMed ID: 26493182
[TBL] [Abstract][Full Text] [Related]
7. Quality of life in patients with Addison's disease: effects of different cortisol replacement modes.
Riedel M; Wiese A; Schürmeyer TH; Brabant G
Exp Clin Endocrinol; 1993; 101(2):106-11. PubMed ID: 8405139
[TBL] [Abstract][Full Text] [Related]
8. Health-related quality of life in patients waiting for major joint replacement. A comparison between patients and population controls.
Hirvonen J; Blom M; Tuominen U; Seitsalo S; Lehto M; Paavolainen P; Hietaniemi K; Rissanen P; Sintonen H
Health Qual Life Outcomes; 2006 Jan; 4():3. PubMed ID: 16423293
[TBL] [Abstract][Full Text] [Related]
9. Clinical, immunological, and genetic features of autoimmune primary adrenal insufficiency: observations from a Norwegian registry.
Erichsen MM; Løvås K; Skinningsrud B; Wolff AB; Undlien DE; Svartberg J; Fougner KJ; Berg TJ; Bollerslev J; Mella B; Carlson JA; Erlich H; Husebye ES
J Clin Endocrinol Metab; 2009 Dec; 94(12):4882-90. PubMed ID: 19858318
[TBL] [Abstract][Full Text] [Related]
10. Influence of hydrocortisone dosage scheme on health-related quality of life in patients with adrenal insufficiency.
Bleicken B; Hahner S; Loeffler M; Ventz M; Decker O; Allolio B; Quinkler M
Clin Endocrinol (Oxf); 2010 Mar; 72(3):297-304. PubMed ID: 19508599
[TBL] [Abstract][Full Text] [Related]
11. The effect of co-morbidities on health-related quality of life in patients placed on the waiting list for total joint replacement.
Tuominen U; Blom M; Hirvonen J; Seitsalo S; Lehto M; Paavolainen P; Hietanieni K; Rissanen P; Sintonen H
Health Qual Life Outcomes; 2007 Mar; 5():16. PubMed ID: 17362498
[TBL] [Abstract][Full Text] [Related]
12. What affects the quality of life in autoimmune Addison's disease?
Meyer G; Hackemann A; Penna-Martinez M; Badenhoop K
Horm Metab Res; 2013 Feb; 45(2):92-5. PubMed ID: 23322510
[TBL] [Abstract][Full Text] [Related]
13. Health-related quality of life--using the 15D instrument--of young adults with type 1 diabetes since childhood. Population-based Oulu cohort study of diabetic retinopathy.
Hannula V; Hautala N; Sintonen H; Falck A
Acta Ophthalmol; 2014 May; 92(3):205-8. PubMed ID: 23763986
[TBL] [Abstract][Full Text] [Related]
14. The impact of chronic orofacial pain on health-related quality of life.
Forssell H; Sipilä K; Teerijoki-Oksa T; Vartiainen P; Kautiainen H; Sintonen H; Kalso E
Scand J Pain; 2020 Apr; 20(2):329-338. PubMed ID: 31881002
[TBL] [Abstract][Full Text] [Related]
15. Development of a disease-specific quality of life questionnaire in Addison's disease.
Løvås K; Curran S; Oksnes M; Husebye ES; Huppert FA; Chatterjee VK
J Clin Endocrinol Metab; 2010 Feb; 95(2):545-51. PubMed ID: 20016050
[TBL] [Abstract][Full Text] [Related]
16. Patients with adrenal insufficiency hate their medication: concerns and stronger beliefs about the necessity of hydrocortisone intake are associated with more negative illness perceptions.
Tiemensma J; Andela CD; Pereira AM; Romijn JA; Biermasz NR; Kaptein AA
J Clin Endocrinol Metab; 2014 Oct; 99(10):3668-76. PubMed ID: 25226291
[TBL] [Abstract][Full Text] [Related]
17. Wolff-Parkinson-White syndrome and atrioventricular nodal re-entry tachycardia in a Swedish population: consequences on health-related quality of life.
Walfridsson U; Strömberg A; Janzon M; Walfridsson H
Pacing Clin Electrophysiol; 2009 Oct; 32(10):1299-306. PubMed ID: 19702600
[TBL] [Abstract][Full Text] [Related]
18. Health-Related Quality of Life in Patients with Small Intestine Neuroendocrine Tumors.
Karppinen N; Lindén R; Sintonen H; Tarkkanen M; Roine R; Heiskanen I; Matikainen N; Schalin-Jäntti C
Neuroendocrinology; 2018; 107(4):366-374. PubMed ID: 30293074
[TBL] [Abstract][Full Text] [Related]
19. Health-related quality of life in long-term follow-up of patients with cured TNM Stage I or II differentiated thyroid carcinoma.
Pelttari H; Sintonen H; Schalin-Jäntti C; Välimäki MJ
Clin Endocrinol (Oxf); 2009 Mar; 70(3):493-7. PubMed ID: 18681857
[TBL] [Abstract][Full Text] [Related]
20. Salivary cortisol day curves in Addison's disease in patients on hydrocortisone replacement.
Ross IL; Levitt NS; Van der Walt JS; Schatz DA; Johannsson G; Haarburger DH; Pillay TS
Horm Metab Res; 2013 Jan; 45(1):62-8. PubMed ID: 22893258
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
